Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Non-cash Items (2011 - 2012)

Dexcom (DXCM) reported Non-cash Items of $45.5 million for Q4 2012, up 138.98% year-over-year from $19.0 million in Q1 2012, and up 138.98% on a QoQ basis from $19.0 million in Q4 2011.

Dexcom (DXCM) has 2 years of Non-cash Items data on file, last reported at $45.5 million in Q4 2012.

  • Quarterly Non-cash Items rose 138.98% year-over-year to $45.5 million in Q4 2012, while the trailing twelve-month figure through Dec 2012 was $45.5 million (up 138.98% YoY) and the FY2012 annual result came in at $45.5 million, up 138.98% from the prior year.
  • Non-cash Items advanced to $45.5 million in Q4 2012 per DXCM's latest filing, from $19.0 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $45.5 million in Q4 2012 and bottomed at $19.0 million in Q4 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2012 45.50 Mn
Dec 31, 2012 45.50 Mn
Dec 31, 2011 19.04 Mn
Dec 31, 2011 19.04 Mn